If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
TREATMENT STRATEGIES
ONCOLOGY
REPRINT
Transdermal Buprenorphine: A Review of its
Role in the Management of Cancer Pain
Bart Van den Eynden
Medical Director, Centre for Palliative Care Sint-Camillus, Chair of
Palliative Medicine, Department of Primary and Interdisciplinary
Health Care, University of Antwerp
Available online at
www.cambridgeresearchcentre.co.uk
Treatment Strategies - Pain Management
Transdermal Buprenorphine: A Review of its Role
in the Management of Cancer Pain
a report by Bart Van den Eynden
Medical Director, Centre for Palliative Care Sint-Camillus, Chair of Palliative Medicine, Department of Primary and Interdisciplinary
Health Care, University of Antwerp
Cancer Pain
In 34-35% of newly diagnosed or early stage cancer patients, pain is
present, but the incidence rises to nearly 70% in patients with
advanced cancer.1 30-40%
TREATMENT STRATEGIES ONCOLOGY REPRINT Tran
Treatment Strategies - Pain Management Tra
differences that contribute to its unique clinica
Treatment Strategies - Pain Management depres
35 μg/h (immediate release morphine was proposed
Treatment Strategies - Pain Management t"QQMZ
Treatment Strategies - Pain Management Journ
Reprinted by the Cambridge Research Centre.